facebook pixel Skip to main content

Join Daniel Dowd, PharmD, for a free webinar to review the genetic variations that can predispose certain patients towards specific behavior and mental health conditions. You’ll learn about BDNF, COMT, SLC6A4 and CRHR1; the mechanisms by which these variants can create a bias, and more!

Enroll & Watch for Free
Daniel Dowd PharmD, Genomind
  • Presenters: Daniel Dowd, PharmD

  • Dates: December 14, 2023

  • Format: 1 hr webinar recording
  • Registration: Free

It is well established that our behaviors are influenced by our environment, experiences, and genetics. While most genes have a very small influence on behaviors, some can create a predisposition towards certain characteristics or traits. In this webinar, Dr. Daniel Dowd, Genomind’s Senior Vice President of Medical Affairs, discusses genes such as BDNF, COMT, SLC6A4 and CRHR1 and the mechanisms by which these variants can create a bias towards some behaviors. He also discusses supplements that may target the biochemistry associated with these genes.

Prescribers > Attend this webinar and get a FREE Genomind PGx test kit! If you were unable to attend the webinar, but would like the free test, please email Heather at hgetz@psychiatryredefined.org by December 31st to get the free test offer details. The free test is only available to prescribers. You must provide licensing credentials at the time of the test order.

This webinar is sponsored by Genomind, whose mission is to optimize the treatment experience for individuals and healthcare providers by unlocking the value of precision medicine through actionable genetic insights and innovative health technology. Learn more about Genomind below!

Enroll & Watch for Free

Our mission is to optimize the treatment experience for individuals and healthcare providers by unlocking the value of precision medicine through actionable genetic insights and innovative health technology.

 

Every year millions of people struggle through trial-and-error treatment or encounter preventable health complications due to adverse drug events. Annually, the societal costs to the healthcare industry are over $358 billion. Until recently, the information to help reduce guesswork, identify adverse drug events, and make personalized treatment decisions was lacking.

There is no one-size-fits all treatment, and Genomind’s platform was developed to unlock the potential of truly personalized medicine. With our comprehensive precision health platform, healthcare providers can quickly assess drug-drug, gene-drug, and drug-drug-gene interactions to deliver safer and more targeted approaches to treatment.

While our heritage is rooted in mental health PGx testing, we have grown to include a broader scope of conditions. Keeping a keen focus on the customer experience and maintaining a deep understanding of challenges faced in our health system, we create innovative solutions that make a meaningful difference in the lives of millions. Together, we can reduce costs, improve quality of care and increase patient and healthcare provider satisfaction.

That’s the science behind better.

Let’s redefine mental wellness together.

Sign-up now for the latest in functional news and research, course launches, exclusive offers and more.

By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.